Skip to main content

Table 5 Discrepancy between CMA and karyotype analysis

From: Chromosome microarray analysis combined with karyotype analysis is a powerful tool for the detection in pregnant women with high-risk indicators

Methods

Anuiploidy

CNVs (P + LP)

BCAs

common

translocatrion

mosaic

CMA

148

0

10

0

0

Karyotype

144

4

13

0

38

  1. BCAs: balanced chromosome abnormalities; P: pathogenic; LP: likely pathogenic.